Short interest in Entrada Therapeutics Inc (NASDAQ:TRDA) increased during the last reporting period, rising from 1.65M to 1.66M. This put 7.12% of the company's publicly available shares short.

Short interest for Entrada Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Entrada Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 71.82K shares traded per day, it would take 23.18 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.